SNSE
Sensei Biotherapeutics Inc
NASDAQ: SNSE · HEALTHCARE · BIOTECHNOLOGY
$26.62
-5.94% today
Updated 2026-04-30
Market cap
$39.04M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-16.72
Dividend yield
—
52W range
$5 – $37
Volume
0.1M
WallStSmart proprietary scores
21
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$50.00
+87.83%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-3.86M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-48.81M | $-34.10M | $-30.16M | $-21.09M | $-4.72M |
| EPS | — | — | — | — | $-16.72 |
| Free cash flow | $-39.35M | $-32.20M | $-24.82M | $-20.47M | $-3.86M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Sensei Biotherapeutics Inc trades at $26.62. Our Smart Value Score of 21/100 indicates the stock is weak.
Frequently asked questions
What is Sensei Biotherapeutics Inc's stock price?
Sensei Biotherapeutics Inc (SNSE) trades at $26.62.
Is Sensei Biotherapeutics Inc overvalued?
Smart Value Score 21/100 (Grade F, Strong Sell).
What is the price target of Sensei Biotherapeutics Inc (SNSE)?
The analyst target price is $50.00, representing +87.8% upside from the current price of $26.62.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-74.00%
Beta-0.10
50D MA$30.11
200D MA$14.42
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—